| This week's sponsor is Premier Research. | |  | Tackling gene therapy's biggest challenges
Gene therapy holds great promise, but despite revolutionary advances, a clear path from bench to bedside remains elusive. Download the white paper for more tips on seizing this unprecedented opportunity. Premier Research. Built for biotech.
Visit us at BIO International, Booth 4049 to learn more. |
Today's Rundown Featured Story | | | Wednesday, June 5, 2019 Bristol-Myers Squibb has unveiled the new-look team that will lead its R&D group after the closure of its Celgene takeover. The Big Pharma is dividing the group up into early- and late-phase development, handing Celgene’s Rupert Vessey responsibility for the former and hiring Novartis’ Samit Hirawat to run the latter. |
|
|
 | Thank you to Lonza for sponsoring this week's coverage of BIO. |
Top Stories Wednesday, June 5, 2019 Sabrina Johnson discusses her journey from a CNS-focused biotech to founding her own women's health company. Wednesday, June 5, 2019 PHILADELPHIA—EpimAb Therapeutics reeled in a $74 million series B to build out its bispecifics pipeline and advance its lead program, an antibody that targets EGFR and cMET on track to enter phase 2 in 2020. Monday, June 3, 2019 Pharma and biopharma have endless data at their disposal. Why aren't they using it? Here's how to make the most of your data for clinical success. Wednesday, June 5, 2019 Lung Therapeutics has raised a $36 million series C round to take a treatment for a serious complication of pneumonia through phase 2 studies. Wednesday, June 5, 2019 Venture capital firm Deerfield Management has committed up to $130 million for a long-term drug discovery collaboration deal with Columbia University. | This week's sponsor is LabConnect. | |  |
LabConnect offers innovative project & data management services connecting samples to data. We customize services to meet the unique needs of clients and their clinical studies. LabConnect is your connection to confidence. Contact us to learn more. |
Resources Sponsored by: Reprints Desk, Inc. Get 5 quick tips for faster research and better results! Sponsored by: Blue Latitude Health In this publication, Blue Latitude Health maps the journey of stakeholders impacted by the rise of precision medicine today. Download the report. Sponsored by: Patheon, by Thermo Fisher Scientific Increase Safety & Flexibility with Flow Chemistry Sponsored by: Veeva IONIS shares best practices for implementing an end-to-end RIM solution in this on-demand webinar. Watch now. Sponsored by: WCG Increasingly complex clinical trials place a tremendous burden on study sites, exacerbating already-troubling recruitment and enrollment issues. Overwhelmed, many sites may not be up to the task or have the appropriate infrastructure, creating costly delays that keep new therapies from patients. Sponsored by: Catalent Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study. Sponsored by: Catalent Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels. Sponsored by: Catalent Download the eBook to explore a proactive approach for clinical supply management. Sponsored by: Catalent Download the executive summary to learn key considerations for a successful technology transfer for manufacturing drug products, including a case study on overcoming challenges in a process transfer for a sterile diluent. Sponsored by: Patheon, part of Thermo Fisher Scientific Choosing the Best Sterile Dosage Form for Your Phase I Clinical Supply Needs. Sponsored by: Patheon, part of Thermo Fisher Scientific Designed with speed & flexibility,Quick to Clinic™ for Oral Solid Dose helps deliver products to Phase I Clinic in as little as 14 weeks. | 
.jpeg/original%20(1).jpeg/db3cd880f0be6707aba09399894aa568)
